TFEB-associated renal cell carcinoma: A case report and literature review

Medicine (Baltimore). 2022 Dec 16;101(50):e31870. doi: 10.1097/MD.0000000000031870.

Abstract

Rationale: TFEB-associated renal cell carcinoma is very rare and belongs to the microphthalmia - associated transcription family translocation renal cell carcinoma.

Patient concerns: Hospitalized for fever, a 29-year-old male patient had a left kidney lesion without any additional discomfort.

Diagnoses: Histopathological and immunohistochemical results were corresponding with TFEB renall cell carcinoma features.

Interventions: Surgical resection of the tumor was performed.

Outcomes: After 8 months of follow-up, no tumor recurrence was observed.

Lessons: TFEB-associated renal cell carcinoma is rare. The diagnosis is explicit. However, the optimal treatment needs to be further explored.

Publication types

  • Review
  • Case Reports

MeSH terms

  • Adult
  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors / genetics
  • Biomarkers, Tumor
  • Carcinoma, Renal Cell* / diagnosis
  • Carcinoma, Renal Cell* / genetics
  • Carcinoma, Renal Cell* / surgery
  • Humans
  • Kidney Neoplasms* / pathology
  • Male
  • Neoplasm Recurrence, Local
  • Translocation, Genetic

Substances

  • Biomarkers, Tumor
  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
  • TFEB protein, human